FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020559061> ?p ?o ?g. }

• W2020559061 endingPage "156" @default.
• W2020559061 startingPage "142" @default.
• W2020559061 abstract "The new World Health Organization (WHO) diagnostic criteria for essential thrombocythemia (ET) issued in 2008 made an important distinction between true ET and early myelofibrosis (MF), which has helped to identify a more homogenous population for the diagnosis with longer survival and much less transformation to overt MF. The recent finding of a new mutation (CALR), which is mutually exclusive with JAK2 and MPL mutations, adds to the characterization of ET patients, since there are important phenotypic differences between the mutation types. CALR patients are younger, have lower white blood cell counts (WBC) and a lower thrombosis incidence. A growing field of interest is the state of hypercoagulation due to dysfunction of hemostatic systems, cell-cell interaction and hereditary prothrombotic traits. Activation of platelets, WBC and endothelial cells has been found, making the whole intravascular milieu prothrombotic. Several risk score models, based on retrospective studies, have been developed lately, distinguishing patient groups with graded risk for complications and death. Even if these may be helpful in evaluating patients, they have not been validated in prospective studies and there are not enough data to support their use as a basis for treatment algorithms. The traditional risk factors age, previous thrombosis and platelets >1500 × 10(9)/l are still recommended for the distinction between high risk and low risk ET and the decision to give cytoreductive therapy. However, cardiovascular (CV) risk factors add to thrombosis risk and should be considered both for specific treatment in any risk group and for upgrading low risk patients with high CV risk to an intermediary group where active therapy with aspirin and cytoreduction may be considered. First-line cytoreductive therapy differs with age; in younger patients interferon (IFN) or anagrelide are preferable, in older patients hydroxycarbamide (HC). Second-line therapy for younger patients is HC, for older patients IFN or anagrelide (ANA). JAK2 inhibitors may be suitable in rare cases with symptoms not responding to other therapy." @default.
• W2020559061 created "2016-06-24" @default.
• W2020559061 creator A5012374853 @default.
• W2020559061 date "2015-04-29" @default.
• W2020559061 modified "2023-09-26" @default.
• W2020559061 title "Advances and challenges in the management of essential thrombocythemia" @default.
• W2020559061 cites W1250526649 @default.
• W2020559061 cites W1480729244 @default.
• W2020559061 cites W1482355610 @default.
• W2020559061 cites W1484059621 @default.
• W2020559061 cites W1512712100 @default.
• W2020559061 cites W1583468714 @default.
• W2020559061 cites W1861885311 @default.
• W2020559061 cites W1910376846 @default.
• W2020559061 cites W1969059748 @default.
• W2020559061 cites W1971236510 @default.
• W2020559061 cites W1972505167 @default.
• W2020559061 cites W1976191601 @default.
• W2020559061 cites W1977734898 @default.
• W2020559061 cites W1980428670 @default.
• W2020559061 cites W1980568348 @default.
• W2020559061 cites W1980616014 @default.
• W2020559061 cites W1983262956 @default.
• W2020559061 cites W1983412285 @default.
• W2020559061 cites W1985309783 @default.
• W2020559061 cites W1985994644 @default.
• W2020559061 cites W1986442976 @default.
• W2020559061 cites W1986560933 @default.
• W2020559061 cites W1990387953 @default.
• W2020559061 cites W1990444790 @default.
• W2020559061 cites W1990476076 @default.
• W2020559061 cites W1991096445 @default.
• W2020559061 cites W1991495650 @default.
• W2020559061 cites W1992172697 @default.
• W2020559061 cites W1997087590 @default.
• W2020559061 cites W2000417669 @default.
• W2020559061 cites W2003848871 @default.
• W2020559061 cites W2006814797 @default.
• W2020559061 cites W2008970948 @default.
• W2020559061 cites W2010992436 @default.
• W2020559061 cites W2017299352 @default.
• W2020559061 cites W2018838972 @default.
• W2020559061 cites W2033914091 @default.
• W2020559061 cites W2037516919 @default.
• W2020559061 cites W2041937783 @default.
• W2020559061 cites W2045359989 @default.
• W2020559061 cites W2048488970 @default.
• W2020559061 cites W2049145190 @default.
• W2020559061 cites W2049489739 @default.
• W2020559061 cites W2051259791 @default.
• W2020559061 cites W2051456036 @default.
• W2020559061 cites W2051701782 @default.
• W2020559061 cites W2057360098 @default.
• W2020559061 cites W2057408088 @default.
• W2020559061 cites W2058342200 @default.
• W2020559061 cites W2059649875 @default.
• W2020559061 cites W2064271195 @default.
• W2020559061 cites W2064280190 @default.
• W2020559061 cites W2064812526 @default.
• W2020559061 cites W2067829130 @default.
• W2020559061 cites W2069651950 @default.
• W2020559061 cites W2083635573 @default.
• W2020559061 cites W2084050646 @default.
• W2020559061 cites W2085728504 @default.
• W2020559061 cites W2087934326 @default.
• W2020559061 cites W2092924489 @default.
• W2020559061 cites W2093922788 @default.
• W2020559061 cites W2097692898 @default.
• W2020559061 cites W2100089051 @default.
• W2020559061 cites W2104129123 @default.
• W2020559061 cites W2112316414 @default.
• W2020559061 cites W2113792044 @default.
• W2020559061 cites W2114504948 @default.
• W2020559061 cites W2116813423 @default.
• W2020559061 cites W2117054170 @default.
• W2020559061 cites W2119941797 @default.
• W2020559061 cites W2121462692 @default.
• W2020559061 cites W2123587611 @default.
• W2020559061 cites W2123643903 @default.
• W2020559061 cites W2124554489 @default.
• W2020559061 cites W2131092191 @default.
• W2020559061 cites W2133633030 @default.
• W2020559061 cites W2134871294 @default.
• W2020559061 cites W213852629 @default.
• W2020559061 cites W2138709799 @default.
• W2020559061 cites W2140173164 @default.
• W2020559061 cites W2141249732 @default.
• W2020559061 cites W2144664431 @default.
• W2020559061 cites W2145187040 @default.
• W2020559061 cites W2147349522 @default.
• W2020559061 cites W2147370660 @default.
• W2020559061 cites W2147666686 @default.
• W2020559061 cites W2153170459 @default.
• W2020559061 cites W2157694607 @default.
• W2020559061 cites W2158669800 @default.
• W2020559061 cites W2159205187 @default.
• W2020559061 cites W2159962994 @default.
• W2020559061 cites W2164614721 @default.

• next